Costs of radium-223 and the pharmacy preparation 177Lu-PSMA-I&amp;T for metastatic castration-resistant prostate cancer in Dutch hospitals.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The radiopharmaceuticals radium-223 and the pharmacy preparation 177Lu-PSMA-I&T are reimbursed in the Netherlands for metastatic castration-resistant prostate cancer (mCRPC) treatment. Although shown to be life-prolonging in patients with mCRPC, the treatment procedures associated with these radiopharmaceuticals can be challenging for both patients and hospitals. This study investigates the costs of mCRPC treatment in Dutch hospitals for currently reimbursed radiopharmaceuticals with a demonstrated overall survival benefit.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Med Econ

Title: Journal of medical economics

Publisher: Informa UK Limited

ISSN (Electronic): 1941-837X

ISSN (Print): 1369-6998

Publication date (Electronic): 2023

Volume: 26

Issue: 1

Affiliations

[1 ] Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

[2 ] Asc Academics, Groningen, The Netherlands.

[3 ] Department of Nuclear Medicine, Catherina Hospital Eindhoven, Eindhoven, The Netherlands.

[4 ] Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.

[5 ] Department of Economics, Econometrics & Finance, Faculty of Economics & Business, University of Groningen, Groningen, The Netherlands.

Article

DOI: 10.1080/13696998.2023.2183618

PubMed ID: 36905581

SO-VID: 2a790c96-b653-4d0a-833d-0efc8e71c243

History

Keywords: Metastatic castration-resistant prostate cancer,I15,I1,I, pharmacy preparation,radiopharmaceuticals,coverage,costs,I18

Data availability:

Keywords: Metastatic castration-resistant prostate cancer, I15, I1, I, pharmacy preparation, radiopharmaceuticals, coverage, costs, I18

Comments

Comment on this article

scite_

Cited by 1

Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Authors: Jean DaSilva, Clemens Decristoforo, Robert H. Mach …

See all cited by

Costs of radium-223 and the pharmacy preparation 177Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals.

Read this article at